Search Results - "Harkin, Andrew"

PBMC telomerase activity in depression and the response to electroconvulsive therapy.

Authors: Ryan, Karen M. Finnegan, Martha Harkin, Andrew et al.

Source: European Archives of Psychiatry & Clinical Neuroscience. Oct2021, Vol. 271 Issue 7, p1297-1307. 11p. 1 Chart, 3 Graphs.

Subjects: Electroconvulsive therapy, Mononuclear leukocytes, Telomerase, Hamilton Depression Inventory, DNA polymerases, Ketamine abuse

This result is not displayed to guests.
Login for full access.

Association between psychological measures with inflammatory anddisease-related markers of inflammatory bowel disease.

Authors: Abautret-Daly, Áine Dempsey, Elaine Riestra, Sabino et al.

Source: International Journal of Psychiatry in Clinical Practice. Sep2017, Vol. 21 Issue 3, p221-230. 10p.

Subjects: Biomarkers, Biopsy, C-reactive protein, Mental depression, Gene expression, Inflammatory bowel diseases, Interferons, Interleukins, Questionnaires, Tryptophan, Well-being, Anxiety disorders, Severity of illness index

Trip killers: Addressing a critical knowledge gap in psychedelic research.

Authors: O'Mahony, Brian Harrington, Colm Harkin, Andrew et al.

Source: Journal of Psychopharmacology. May2026, Vol. 40 Issue 5, p687-702. 16p.

Investigation of the mechanisms mediating MDMA 'Ecstasy'-induced increases in cerebro-cortical perfusion determined by btASL MRI.

Authors: Rouine, J Kelly, M. Jennings-Murphy, C. et al.

Source: Psychopharmacology. May2015, Vol. 232 Issue 9, p1501-1513. 13p.

Subjects: Ecstasy (Drug), Perfusion, Magnetic resonance imaging of the brain, Pharmacology, Dopaminergic mechanisms, Propylamine, Chlorophenylalanine

Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism.

Authors: Gigliucci, Valentina O'Dowd, Grainne Casey, Sheena et al.

Source: Psychopharmacology. Jul2013, Vol. 228 Issue 1, p157-166. 10p. 4 Graphs.

Subjects: Ketamine, Antidepressants, Serotonin, Controlled release drugs, Effect of stress on animals, Hydroxytryptophan, Chlorophenylalanine, Scientific observation

Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA (‘ecstasy’).

Authors: Vanattou-Saïfoudine, Natacha McNamara, Ruth Harkin, Andrew

Source: Psychopharmacology. Aug2010, Vol. 211 Issue 1, p15-25. 11p. 3 Graphs.

Subjects: Physiological effects of caffeine, Dopamine receptors, Body temperature, Locomotion, Laboratory rats, Heart rate monitoring, Ecstasy (Drug), Psychology, Physiology, Animal behavior

Adenosine A1 Receptor Blockade Mimics Caffeine's Attenuation of Ethanol-Induced Motor Incoordination.

Authors: Connole, Laura Harkin, Andrew Maginn, Mark

Source: Basic & Clinical Pharmacology & Toxicology. Dec2004, Vol. 95 Issue 6, p299-304. 6p.

A Toxicokinetic Study of Nickel-Induced Immunosuppression in Rats.

Authors: Harkin, Andrew Hynes, Michael J. Masterson, Eoghan et al.

Source: Immunopharmacology & Immunotoxicology. Nov2003, Vol. 25 Issue 4, p655-670. 16p.

Modulation of MK-801-induced behaviour by noradrenergic agents in mice.

Authors: Harkin, Andrew Morris, Kathleen Kelly, John P. et al.

Source: Psychopharmacology. 2001, Vol. 154 Issue 2, p177. 12p. 1 Chart, 8 Graphs.

Subjects: Noradrenaline, Methyl aspartate, Mice, Physiology, Chemicals

Metyrapone displays antidepressant-like properties in preclinical paradigms.

Authors: Healy, David G. Harkin, Andrew Cryan, John F. et al.

Source: Psychopharmacology. 1999, Vol. 145 Issue 3, p303. 6p.

Subjects: Glucocorticoids, Mental depression, Antidepressants, Therapeutics

In memoriam: Brian E. Leonard.

Authors: Wegener, Gregers Harkin, Andrew Cryan, John F.

Source: Acta Neuropsychiatrica. Feb2024, Vol. 36 Issue 1, p63-64. 2p.

Subjects: Tranquilizing drugs, Psychiatric drugs, Clinical biochemistry

Gut–brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease.

Authors: Abautret-Daly, Áine Dempsey, Elaine Parra-Blanco, Adolfo et al.

Source: Acta Neuropsychiatrica. Oct2018, Vol. 30 Issue 5, p275-296. 22p.

Subjects: Comorbidity, Inflammatory bowel diseases, Quality of life, Mental depression, Colitis, Anxiety

A systematic review of manipulations to pharmaceutical dosage forms used in psychotropic tapering plans.

Authors: O'Brien, Denis Healy, Anne Marie Harkin, Andrew et al.

Source: British Journal of Clinical Pharmacology. Jul2025, Vol. 91 Issue 7, p1899-1913. 15p.

Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders.

Authors: O'Farrell, Katherine Harkin, Andrew

Source: Neuropharmacology. Jan2017 Part B, Vol. 112, p307-323. 17p.

This result is not displayed to guests.
Login for full access.

Expression of glucocorticoid inducible genes is associated with reductions in cornu ammonis and dentate gyrus volumes in patients with major depressive disorder.

Authors: Cicchetti, Dante Natsuaki, Misaki N. Frodl, Thomas et al.

Source: Development & Psychopathology. Nov2014, Vol. 26 Issue 4pt2, p1209-1217. 9p.

Subjects: Gene expression, Dentate gyrus, Glucocorticoids, Hippocampus physiology, Depressed persons, Messenger RNA, People with mental illness, Physiology

The PSD-95/nNOS complex: New drugs for depression?

Authors: Doucet, Marika V. Harkin, Andrew Dev, Kumlesh K.

Source: Pharmacology & Therapeutics. Feb2012, Vol. 133 Issue 2, p218-229. 12p.

Chronic Fluoxetine Treatment Attenuates Stressor-Induced Changes in Temperature, Heart Rate, and Neuronal Activation in the Olfactory Bulbectomized Rat.

Authors: Roche, Michelle Harkin, Andrew Kelly, John P

Source: Neuropsychopharmacology. Jun2007, Vol. 32 Issue 6, p1312-1320. 9p. 4 Graphs.

Lipids and essential fatty acids in patients presenting with self-harm.

Authors: Garland, Malcolm R. Hallahan, Brian McNamara, Mairead et al.

Source: British Journal of Psychiatry. Feb2007, Vol. 190, p112-117. 6p. 4 Charts.

Subjects: Cholesterol, Essential fatty acids, Preventive medicine, Serotoninergic mechanisms, Psychometrics